(Q37481361)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441938%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

review article

1 reference

title

New frontiers in cell-based immunotherapy of cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441938%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441938%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Gianfranco Del Prete

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441938%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Amedeo Amedei

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441938%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

English

0 references

publication date

1 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441938%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Patents

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441938%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441938%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441938%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

623-641

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441938%20AND%20SRC:MED&resulttype=core&format=json

The spontaneous regression of cancer. A review of cases from 1900 to 1987.

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Natural killer cells in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

In vivo natural killer cell activities revealed by natural killer cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Use of natural killer cells in hematopoetic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Natural killer cell-based immunotherapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Potent antibody therapeutics by design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Nature's TRAIL--on a path to cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

NKT cells: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Murine CD1d-restricted T cell recognition of cellular lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Differential antitumor immunity mediated by NKT cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Natural killer T cell-mediated antitumor immune responses and their clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to V alpha 24+ NKT cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

[gamma][delta] cells: a right time and a right place for a conserved third way of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

V gamma 9V delta 2 T cell response to colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Activation of V gamma 9V delta 2 T cells by NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Peripheral gammadelta T-lymphocytes as an innovative tool in immunotherapy for metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Principles of adoptive T cell cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Role of stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

What is the impact of hematopoietic cell transplantation (HCT) for older adults with acute myeloid leukemia (AML)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Suicide genes as safety switches in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Addition of the CD28 signaling domain to chimeric T-cell receptors enhances chimeric T-cell resistance to T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Restoration of CD28 expression in CD28- CD8+ memory effector T cells reconstitutes antigen-induced IL-2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Adoptive cellular immunotherapy for EBV lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Adoptive T cell therapy for cancer in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Unique human tumor antigens: immunobiology and use in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

The consensus coding sequences of human breast and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Successful adoptive immunotherapy with vaccine-sensitized T cells, despite no effect with vaccination alone in a weakly immunogenic tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Studies on the immunological response to foreign tumor transplants in the mouse. I. The role of lymph node cells in conferring immunity by adoptive transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Checkpoint blockade in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

Antitumor effects of HSV-TK engineered donor lymphocytes after allogeneic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902817820

10.1517/13543770902817820

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441938%20AND%20SRC:MED&resulttype=core&format=json

release_l4clzoirqrgzvcgfqeysqflmqa

28 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l4clzoirqrgzvcgfqeysqflmqa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference